Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Histiocytoses
ADR ID BADD_A02078
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.04      Histiocytoses
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.04      Histiocytoses
Description General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT. [MeSH]
MedDRA Code 10020118
MeSH ID D015614
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Histiocytosis | Histiocytoses
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D00356Carbamazepine
BADD_D00405Ceftriaxone
BADD_D00511Clozapine
BADD_D00566Dabrafenib
BADD_D00616Desmopressin
BADD_D00858Everolimus
BADD_D00932Fluoxetine
BADD_D01243Lamotrigine
BADD_D01295Linezolid
BADD_D01773Pimecrolimus
BADD_D01834Prednisone
BADD_D02257Trametinib
BADD_D02464Fingolimod
The 1th Page    1    Total 1 Pages